Brief: Neubase Therapeutics Reports Financial Results For The Second Quarter Of Fiscal Year 2021
13/05/2021 21:37
May 13 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE
SECOND
QUARTER OF FISCAL YEAR 2021
* Q2 LOSS PER SHARE $0.24
* Q2 EARNINGS PER SHARE ESTIMATE $-0.22 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNXc2M33v
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet